Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda-Reference-Cited by-同舟云学术

Low Primary and Secondary HIV Drug-Resistance after 12 Months of Antiretroviral Therapy in Human Immune-Deficiency Virus Type 1 (HIV-1)-Infected Individuals from Kigali, Rwanda

Published:2013-08-12 Issue:8 Volume:8 Page:e64345
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Rusine John,Asiimwe-Kateera Brenda,van de Wijgert Janneke,Boer Kimberly Rachel,Mukantwali Enatha,Karita Etienne,Gasengayire Agnes,Jurriaans Suzanne,de Jong Menno,Ondoa Pascale

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference43 articles.

1. World Health Organization (2011) Global AIDS response. Epidemic update and Health sector progress towards universal access. Progress report Geneva. World Health Organization.

2. The WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings;CF Gilks;Lancet,2006

3. HIV and AIDS in Rwanda 2010;Epidemiologic Update,2010

4. The antiretroviral rollout and drug-resistant HIV in Africa: insights from empirical data and theoretical models;S Blower;AIDS,2005

5. The World health organization's global strategy for prevention and assessment of HIV drug resistance;DE Bennet;Antiviral Therapy,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV type 1 drug resistance monitoring in a HIV-1 endemic settings of Kisii, Kenya;2023-08-11

2. HIV-1 genotypic profiling ensures effective response to third-line antiretroviral therapy in Cameroon;Medicine;2023-06-02

3. Dolutegravir-Based Regimen Ensures High Virological Success despite Prior Exposure to Efavirenz-Based First-LINE ART in Cameroon: An Evidence of a Successful Transition Model;Viruses;2022-12-21

4. HIV-1 integrase resistance associated mutations and the use of dolutegravir in Sub-Saharan Africa: A systematic review and meta-analysis;PLOS Global Public Health;2022-10-11

5. Acquired HIV drug resistance among adults living with HIV receiving first-line antiretroviral therapy in Rwanda: A cross-sectional nationally representative survey;Antiviral Therapy;2022-05-20